COSCIENS Biopharma Inc. (TSX:CSCI)
1.110
+0.010 (0.91%)
At close: Mar 20, 2026
COSCIENS Biopharma Market Cap
COSCIENS Biopharma has a market cap or net worth of CAD 3.53 million as of March 20, 2026. Its market cap has decreased by -49.33% in one year.
Market Cap
3.53M
Enterprise Value
-5.31M
Revenue
12.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.11
Market Cap Chart
Since April 22, 1996, COSCIENS Biopharma's market cap has decreased from 14.82B to 3.53M, a decrease of -99.98%. That is a compound annual growth rate of -24.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.53M | -60.91% |
| Dec 31, 2025 | 9.04M | 30.63% |
| Dec 31, 2024 | 6.92M | -44.54% |
| Dec 29, 2023 | 12.48M | -40.23% |
| Dec 30, 2022 | 20.88M | -62.20% |
| Dec 31, 2021 | 55.24M | 63.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptose Biosciences | 5.69M |
| Kane Biotech | 5.46M |
| MYND Life Sciences | 5.22M |
| Quest PharmaTech | 5.07M |
| XORTX Therapeutics | 4.46M |
| Cytophage Technologies | 4.40M |
| MindBio Therapeutics | 4.32M |
| ASEP Medical Holdings | 3.56M |